Search results
Revascularisation in Patients with Cancer
Author(s):
Miguel Nobre Menezes
,
Mamas A Mamas
Added:
2 months ago
Review Article
Anticoagulation in Cardio-oncology
Author(s):
Sebastian Szmit
,
Maciej Krzakowski
,
Dariusz M Kowalski
,
et al
Added:
1 month ago
Review Article
Frailty in Cardio-oncology
Author(s):
Ilaria Torre
,
Lorenzo Tinti
,
Ludovica Amore
,
et al
Added:
2 months ago
Review Article
New Frontiers in Cardioprotection
Author(s):
Giulia Tamburrini
,
Celia de Cobos García
,
Teresa López Fernández
Added:
7 months ago
Review Article
Author(s):
Massimiliano Camilli
,
Luca Maggio
,
Lorenzo Tinti
,
et al
Added:
1 year ago
Author(s):
Harriette Van Spall
,
Isabelle Mahé
Added:
1 year ago
ACC 25 - The API-CAT Study shows reduced-dose apixaban is non-inferior to full-dose apixaban for extended anticoagulation in patients with active cancer who have completed 6 months of anticoagulant therapy for venous thromboembolism (VTE).Late-Breaker host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Prof Isabelle Mahe (Paris Cite University, Paris, FR) to discuss the…
View more
Author(s):
Maria Fernández García
,
Alberto Alen Andrés
,
Beatriz Nieves Ureña
,
et al
Added:
4 days ago
Author(s):
Raúl Ludeña
,
Raúl Ptaszynski Lanza
,
Beatriz Nieves Ureña
,
et al
Added:
4 days ago
Michael D Stubblefield
Author
Frailty and Cardio-oncology
Author(s):
Erkihun Amsalu
,
Tan Van Nguyen
,
Harry Klimis
,
et al
Added:
4 months ago
Review Article